| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
4,331 |
3,910 |
$72K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,820 |
1,565 |
$71K |
| 80061 |
Lipid panel |
4,332 |
3,908 |
$59K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,537 |
5,805 |
$46K |
| 80053 |
Comprehensive metabolic panel |
4,205 |
3,794 |
$45K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,385 |
1,236 |
$37K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,311 |
2,089 |
$22K |
| 81000 |
|
5,486 |
4,873 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
411 |
383 |
$14K |
| 84439 |
|
1,601 |
1,443 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
398 |
370 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,460 |
1,296 |
$12K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
417 |
391 |
$9K |
| 86328 |
|
342 |
324 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
298 |
283 |
$6K |
| 82607 |
|
411 |
382 |
$6K |
| 82274 |
|
395 |
347 |
$6K |
| 87088 |
|
678 |
591 |
$5K |
| 82043 |
|
764 |
694 |
$4K |
| 86592 |
|
810 |
745 |
$3K |
| 82570 |
|
678 |
620 |
$3K |
| 84153 |
|
178 |
149 |
$3K |
| 87276 |
|
122 |
96 |
$1K |
| 87275 |
|
122 |
96 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
175 |
152 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
670 |
608 |
$1K |
| 85732 |
|
65 |
62 |
$414.15 |
| 85610 |
|
83 |
74 |
$307.98 |
| 86701 |
|
26 |
26 |
$242.25 |
| 82947 |
|
57 |
52 |
$219.16 |
| 84479 |
|
68 |
61 |
$214.41 |
| 84436 |
|
29 |
25 |
$155.83 |
| 87177 |
|
12 |
12 |
$71.22 |
| 85651 |
|
30 |
29 |
$47.32 |